NCT03819231 (MOXY) is a Phase 2, PHASE3 clinical trial of Oxytocin in Smoking, sponsored by University of Southern California.

Who is sponsoring NCT03819231?

NCT03819231 is sponsored by University of Southern California.

What drugs are being tested in NCT03819231?

Interventions in NCT03819231: Oxytocin, Mindfulness, Saline Solution, Sham mindfulness.

What condition does NCT03819231 study?

NCT03819231 studies Smoking, Smoking Cessation.

Is NCT03819231 still recruiting?

NCT03819231 is currently terminated. Last updated 14 June 2024.

Last reviewed 2024-06-14 · How we verify

NCT03819231: MOXY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness Training Plus Oxytocin Effects on Smoking Behavior

Terminated Phase 2, PHASE3 Last updated 14 June 2024

What this trial tests

Phase 2, PHASE3 trial testing Oxytocin in Smoking in 20 participants. Terminated before completion.

Timeline

10 October 2018

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	University of Southern California
Phase	Phase 2, PHASE3
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	double
Primary purpose	basic science
Enrollment	20
Start date	10 October 2018
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across United States

Drugs / interventions tested

Oxytocin (OXYTOCIN) — full drug profile →
Mindfulness
Saline Solution
Sham mindfulness

Conditions studied

Smoking — all drugs for Smoking →
Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

University of Southern California

Who can join

Adults 18 to 40, any sex, with Smoking or Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the effects of mindfulness training and a drug called oxytocin on smoking.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oxytocin

Trials testing the same drug.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07188207 — Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section · NA · not yet recruiting
NCT06968481 — Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage · Phase 2 · not yet recruiting
NCT07265180 — Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison · NA · recruiting
NCT07119398 — Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM · Phase 4 · recruiting

Other recruiting trials for Smoking

Currently open trials in the same condition.

NCT07488741 — Comparison of the Effects of Different Chest Techniques on University Students With Smoking Addiction · NA · recruiting
NCT07443631 — Assessment of HPHC Exposure in Smokers Switching to THS/TP18 With Different Device Variants · NA · recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT06713603 — Technology Assisted Motivational Interviewing · NA · recruiting

Other University of Southern California trials

Trials by the same sponsor.

NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03819231 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Southern California
Last refreshed: 14 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing